Susquehanna International Group, LLP Affimed N.V. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.32 - $0.62 $3,400 - $6,589	10,628 Added 56.85%	29,324 $18,000
Q3 2023 Nov 14, 2023	SELL	$0.46 - $0.65 $37,688 - $53,255	-81,931 Reduced 81.42%	18,696 $8,000
Q2 2023 Aug 11, 2023	SELL	$0.57 - $1.08 $11,920 - $22,587	-20,914 Reduced 17.21%	100,627 $60,000
Q1 2023 May 16, 2023	BUY	$0.66 - $1.29 $15,348 - $30,000	23,256 Added 23.66%	121,541 $91,000
Q4 2022 Feb 14, 2023	SELL	$1.1 - $2.45 $6,805 - $15,158	-6,187 Reduced 5.92%	98,285 $121,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $105,879 - $179,346	54,020 Added 107.07%	104,472 $215,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $82,605 - $176,855	36,390 Added 258.78%	50,452 $140,000
Q1 2022 May 16, 2022	SELL	$3.69 - $5.65 $295,886 - $453,050	-80,186 Reduced 85.08%	14,062 $61,000
Q4 2021 Feb 14, 2022	BUY	$5.37 - $7.07 $192,605 - $253,579	35,867 Added 61.44%	94,248 $520,000
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $286,323 - $388,139	-51,683 Reduced 46.96%	58,381 $361,000
Q2 2021 Aug 11, 2021	BUY	$7.78 - $11.4 $493,695 - $723,409	63,457 Added 136.15%	110,064 $936,000
Q1 2021 May 17, 2021	SELL	$5.12 - $8.48 $208,716 - $345,687	-40,765 Reduced 46.66%	46,607 $369,000
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $3,494 - $7,775	-1,106 Reduced 1.25%	87,372 $509,000
Q3 2020 Nov 16, 2020	BUY	$3.26 - $4.73 $250,729 - $363,789	76,911 Added 664.92%	88,478 $300,000
Q2 2020 Aug 14, 2020	SELL	$1.58 - $4.63 $35,598 - $104,318	-22,531 Reduced 66.08%	11,567 $53,000
Q1 2020 May 15, 2020	BUY	$1.44 - $3.02 $27,771 - $58,243	19,286 Added 130.21%	34,098 $54,000
Q4 2019 Feb 14, 2020	SELL	$2.25 - $3.07 $87,423 - $119,284	-38,855 Reduced 72.4%	14,812 $41,000
Q3 2019 Nov 14, 2019	SELL	$2.67 - $3.65 $65,973 - $90,187	-24,709 Reduced 31.53%	53,667 $158,000
Q2 2019 Aug 16, 2019	BUY	$2.6 - $4.21 $62,813 - $101,709	24,159 Added 44.56%	78,376 $225,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $26,353 - $42,672	10,136 Added 22.99%	54,217 $156,000
Q1 2019 May 15, 2019	SELL	$3.05 - $4.34 $386,123 - $549,435	-126,598 Reduced 74.17%	44,081 $185,000
Q4 2018 Feb 14, 2019	BUY	$2.82 - $4.67 $355,926 - $589,424	126,215 Added 283.86%	170,679 $531,000
Q3 2018 Nov 14, 2018	BUY	$1.45 - $6.15 $64,472 - $273,453	44,464 New	44,464 $193,000
Q2 2018 Aug 14, 2018	SELL	$1.65 - $2.5 $40,217 - $60,935	-24,374 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.25 - $2.65 $30,467 - $64,591	24,374 New	24,374 $45,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account